Pembrolizumab‐induced myasthenia gravis with myositis in a patient with lung cancer

In the new era of cancer immunotherapy, clinical research has uncovered diverse and unpredictable immune‐related adverse events. Here, we report the first case of pembrolizumab‐induced myasthenia gravis (MG) and myositis in a patient with lung cancer. The patient developed symptoms after the second...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Respirol Case Rep
Hlavní autoři: Hibino, Makoto, Maeda, Kazunari, Horiuchi, Shigeto, Fukuda, Minoru, Kondo, Tetsuri
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons, Ltd 2018
Témata:
Case Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6079932/
https://ncbi.nlm.nih.gov/pubmed/30094028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rcr2.355
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky